MRVL vs NKE: Which Is the Better Buy?

Side-by-side comparison of Marvell Technology, Inc. and NIKE, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-07-01.
Marvell Technology, Inc. Β· Technology
$310.58
-18.5% upside to fair value
Grade D
VS
NIKE, Inc. Β· Consumer Cyclical
$41.05
+45.0% upside to fair value
Grade B High Quality
QuantHub Verdict
NKE has more upside to fair value (+45.0%). NKE trades at a lower forward P/E (19.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRVL NKE
Current Price $310.58 $41.05
Fair Value Estimate $253.23 $59.52
Upside to Fair Value -18.5% +45.0%
Market Cap $271.7B $60.7B
Forward P/E 105.7x 19.6x
EV / EBITDA 59.1x 14.2x
Price / Sales 31.2x 1.3x
Price / FCF 163.2x 57.9x
Revenue Growth YoY +27.6% -1.1%
Gross Margin 50.6% 42.9%
Operating Margin 16.2% 8.2%
Return on Equity 16.8% 22.0%
Dividend Yield 0% 0%
FCF Yield 0.61% 1.73%
Analyst Consensus Strong Buy Hold
Investment Thesis
MRVL β€” Marvell Technology, Inc.
Marvell Technology, Inc. designs and supplies semiconductor solutions primarily focused on data infrastructure markets including cloud, AI, carrier 5G, and custom silicon. The company benefits from a narrow but widening moat driven by strong IP and hyperscaler relationships, led by an experienced CEO with a track record of transformational M&A. Despite strong revenue growth of 42% year-over-year …
NKE β€” NIKE, Inc.
NIKE, Inc. is a leading global athletic footwear and apparel company with a durable competitive moat supported by its strong brand, scale, and global distribution infrastructure. The company is currently led by CEO Elliott Hill, a seasoned Nike veteran who returned in October 2024 to navigate intensifying competition and channel complexity. Despite its market leadership and solid profitability me…
Accumulation Zones
Metric MRVL NKE
Zone Low $189.92 $44.64
Zone High $215.25 $50.59
In Buy Zone? No Yes
← MRVL Research    NKE Research β†’    All Research